|
||
Pubergen Uses |
||
this medicine PreFilled Syringe (choriogonadotropin alfa injection) is indicated for the induction of final follicular maturation and early luteinization in infertile women who have undergone pituitary desensitization and who have been appropriately pretreated with follicle stimulating hormones as part of an Assisted Reproductive Technology (ART) program such as in vitro fertilization and embryo transfer. this medicine PreFilled Syringe is also indicated for the induction of ovulation (OI) and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure.
Selection of Patients
1.
Before treatment with gonadotropins is instituted, a thorough gynecologic and endocrinologic evaluation must be performed. This should include an assessment of pelvic anatomy. Patients with tubal obstruction should receive this medicine PreFilled Syringe only if enrolled in an in vitro fertilization program.
2.
Primary ovarian failure should be excluded by the determination of gonadotropin levels.
3.
Appropriate evaluation should be performed to exclude pregnancy.
4.
Patients in later reproductive life have a greater predisposition to endometrial carcinoma as well as a higher incidence of anovulatory disorders. A thorough diagnostic evaluation should always be performed in patients who demonstrate abnormal uterine bleeding or other signs of endometrial abnormalities before starting FSH and this medicine PreFilled Syringe therapy.
5.
Evaluation of the partner
This medication is a hormone used in boys (before puberty) to cause the normal dropping of the testicles into the scrotum. It is also used in certain boys to help with normal sexual development. It works by causing the testes to release male sex hormones (e.g., testosterone).
This medication is also used in women to treat fertility problems. It is given after finishing another medication (menotropins) to cause the release of an egg (ovulation). It should not be used in women whose ovaries no longer make eggs properly (primary ovarian failure).
This medication has not been shown to be effective for weight loss and should not be used for this purpose.
This medication is given by injection into a muscle by a health care professional. If you are giving this medication at home, learn all preparation and usage instructions for this product. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. If you have any questions about the use of this medication, ask your doctor or pharmacist.
The dosage is based on your age, weight, medical condition, and response to treatment.
For boys, use this medication usually 3 times a week or as directed by your doctor. For women, use this medication usually for 1 dose after finishing your menotropins treatment.
Use this medication regularly to get the most benefit from it. To help you remember, mark the day(s) on the calendar when you need to receive the medication.
Learn how to store and discard needles and medical supplies safely. Consult your pharmacist for more details.
Each vial with powder of Pubergen contains Chorionic Gonadotrophin (HCG) 5,000 IU as the active ingredient and lactose as further ingredient.
Each ampoule with 1 mL solvent of Pubergen contains isotonic sodium chloride solution and dilute hydrochloric acid for pH adjustment.
Female: To Induce Ovulation: 5,000 or 10,000 IU injected once IM.
To Maintain Corpus Luteum Function: 1,500-5,000 IU to be injected IM on the 3rd, 6th and 9th day following ovulation. If desired, Pubergen 1500 can be used.
Male: To Induce Puberty in Boys with Pubertas Tarda: 3,000-5,000 IU IM once a week over a period of 3 months. If desired, Pubergen 1500 can be used.
Hypogonadotrophic Hypogonadism (together with HMG): 1,500-6,000 IU IM per week. If desired, Pubergen 1500 can be used.
As a Diagnostic Agent: For Differential Diagnosis in Boys with Undescended Testicle and to Assess the Function of the Testes in Patients with Hypogonadotrophic Hypogonadism: One (1) time injection of 5,000 IU IM.
Administration: Pubergen is to be injected IM.
Drug/Laboratory Test Interactions
The following laboratory results may be altered by the use of estrogen-progestin combination drugs:
Fasting and 2-hour plasma insulin and glucose levels following an oral glucose tolerance test (OGTT) and figrinogen levels were measured in patients receiving PROMETRIUM® Capsules at a dose of 200 mg/day for 12 days per 28 day cycle in combination with conjugated estrogens 0.625 mg/day (n-120). Table 6 summarizes this data. Plasma insulin levels 2 hours post-OGTT were decreased from baseline. The fasting plasma glucose and fasting plasma insulin levels were also decreased from baseline. Glucose levels 2 hours post-OGTT were increased slightly. There was no effect on fibrinogen levels.
For information on changes in lipid profile, see the CLINICAL PHARMACOLOGY, Clinical Studies subsection, Table 5.
Table 6
The following adverse reactions have been previously reported during menotropin therapy:
1.Pulmonary and vascular complications
2.Adnexal torsion (as a complication of ovarian enlargement)
3. Mild to moderate ovarian enlargement
4.Hemoperitoneum
The following medical events have been reported subsequent to pregnancies resulting from hCG therapy in controlled clinical studies:
1.Spontaneous Abortion
2.Ectopic Pregnancy
3.Premature Labor
4.Postpartum Fever
5.Congenital abnormalities
Preferred Term : At Least One Adverse Event
Incidence Rate % (n): 33.1% (78)
Preferred Term : APPLICATION SITE DISORDERS
Incidence Rate % (n): 14.0% (33)
Preferred Term : INJECTION SITE PAIN
Incidence Rate % (n): 7.6% (18)
Preferred Term : INJECTION SITE BRUISING
Incidence Rate % (n): 4.7% (11)
Preferred Term : GASTRO-INTESTINAL SYSTEM DISORDERS
Incidence Rate % (n): 8.5% (20)
Preferred Term : ABDOMINAL PAIN
Incidence Rate % (n): 4.2% (10)
Preferred Term : NAUSEA
Incidence Rate % (n): 3.4% (8)
Preferred Term : VOMITING
Incidence Rate % (n): 2.5% (6)
Preferred Term : SECONDARY TERMS (POST-OPERATIVE PAIN)
Incidence Rate % (n): 4.7% (11)
Preferred Term : POST-OPERATIVE PAIN
Incidence Rate % (n): 4.7% (11)
PROMETRIUM Capsules should not be used in women with any of the following conditions:
1. PROMETRIUM Capsules should not be used in patients with known hypersensitivity to its ingredients. PROMETRIUM Capsules contain peanut oil and should never be used by patients allergic to peanuts.
Chorionic Gonadotrophin in India.
Human chorionic gonadotrophin in India.
Unit description / dosage (Manufacturer) | Price, USD |
PUBERGEN Injection / 10000 i.u. / 1 units (Uni - Sankyo) | $ 6.77 |
PUBERGEN Injection / 5000 i.u. / 1 units (Uni - Sankyo) | $ 4.55 |
PUBERGEN Injection / 2000 i.u. / 1 units (Uni - Sankyo) | $ 3.25 |
PUBERGEN Injection / 1000 i.u. / 1 units (Uni - Sankyo) | $ 2.29 |
1000 IU x 1's | $ 2.30 |
2000 IU x 1's | $ 3.22 |
5000 IU x 1's | $ 4.55 |
10000 IU x 1's | $ 6.60 |
Pubergen 1000 IU AMP / 1 | $ 2.30 |
Pubergen 2000 IU AMP / 1 | $ 3.22 |
Pubergen 5000 IU AMP / 1 | $ 4.55 |
Pubergen 10000 IU AMP / 1 | $ 6.60 |
PUBERGEN 10000IU INJECTION 1 vial / 1 injection each (Sanzyme Ltd) | $ 8.39 |
PUBERGEN 1000IU INJECTION 1 vial / 1 ML injection each (Sanzyme Ltd) | $ 2.93 |
PUBERGEN 2000IU INJECTION 1 vial / 1 ML injection each (Sanzyme Ltd) | $ 4.07 |
PUBERGEN 5000IU INJECTION 1 vial / 1 ML injection each (Sanzyme Ltd) | $ 6.99 |
Pubergen 10000IU Injection (Sanzyme Ltd) | $ 8.39 |
Pubergen 1000IU Injection (Sanzyme Ltd) | $ 2.93 |
Pubergen 2000IU Injection (Sanzyme Ltd) | $ 4.07 |
Pubergen 5000IU Injection (Sanzyme Ltd) | $ 4.79 |
List of Pubergen substitutes (brand and generic names): | |
Provigil-HP (India) | |
10000 IU x 1's (Svizera) | $ 10.24 |
PUBERGEN AQUA | |
PUBERGEN AQUA 5000 IU INJECTION 1 vial / 1 ML injection each (Sanzyme Ltd) | $ 6.99 |
Pubergen Aqua 5000IU Injection (Sanzyme Ltd) | $ 6.99 |
PUBERGEN HP | |
PUBERGEN HP 2000IU INJECTION 1 vial / 1 injection each (Sanzyme Ltd) | $ 3.04 |
PUBERGEN HP 5000IU INJECTION 1 vial / 1 injection each (Sanzyme Ltd) | $ 7.10 |
Pubergen HP 5000IU Injection (Sanzyme Ltd) | $ 7.10 |
PUBERGEN JO | |
PUBERGEN JO 7500IU INJECTION 1 vial / 1 ML injection each (Sanzyme Ltd) | $ 7.27 |
PUBERGEN NANO | |
PUBERGEN NANO 500IU INJECTION 1 vial / 1 ML injection each (Sanzyme Ltd) | $ 2.60 |
Pubergen-HP (India) | |
Pubergen-HP 2000 IU AMP / 1 (Uni Sankyo) | $ 6.60 |
2000 IU x 1's (Uni Sankyo) | $ 6.60 |
ROGON-HP (India) | |
ROGON-HP inj 5000 IU x 1's (Rowez) | $ 4.70 |
SIFASI | |
SIFASI 5000IU INJECTION 1 vial / 1 ML injection each (Serum Institute) | $ 4.64 |
SIFASI inj 2000 IU x 1's (Serum Institute) | $ 4.37 |
SIFASI inj 5000 IU x 1's (Serum Institute) | $ 5.96 |
SIFASI inj 10000 IU x 1's (Serum Institute) | $ 11.27 |
Sifasi 10000IU Injection (Serum Institute) | $ 11.27 |
SIFASI HP | |
SIFASI HP 10000 IU INJECTION 1 vial / 10 ML injection each (Serum Institute Of India Ltd) | $ 13.12 |
SIFASI HP 2000 IU INJECTION 1 vial / 1 ML injection each (Serum Institute Of India Ltd) | $ 5.10 |
SIFASI HP 5000 IU INJECTION 1 vial / 1 ML injection each (Serum Institute Of India Ltd) | $ 4.64 |
Sifasi HP 10000IU Injection (Serum Institute Of India Ltd) | $ 1.31 |
Sifasi HP 2000IU Injection (Serum Institute Of India Ltd) | $ 5.10 |
Sifasi HP 5000IU Injection (Serum Institute Of India Ltd) | $ 4.72 |
SIFASI-HP (India) | |
SVEN HCG | |
SVEN HCG 5000 IU INJECTION 1 vial / 1 injection each (Sven Genetech Ltd) | $ 2.17 |
Sven Hcg 5000IU Injection (Sven Genetech Ltd) | $ 2.17 |
Syncropart (Israel) | |
TRIGOVA HP | |
TRIGOVA HP 10000IU INJECTION 1 vial / 1 injection each (Glenmark Pharmaceuticals Ltd) | $ 10.60 |
TRIGOVA HP 2000IU INJECTION 1 vial / 1 ML injection each (Glenmark Pharmaceuticals Ltd) | $ 4.34 |
TRIGOVA HP 5000IU INJECTION 1 vial / 1 ML injection each (Glenmark Pharmaceuticals Ltd) | $ 6.33 |
Trigova HP 2000IU Injection (Glenmark Pharmaceuticals Ltd) | $ 4.34 |
Trigova HP 5000IU Injection (Glenmark Pharmaceuticals Ltd) | $ 6.33 |
Trigova-HP (India) | |
Trigova-HP 2000 IU AMP / 1 (Glenmark (G&G)) | $ 4.75 |
Trigova-HP 5000 IU AMP / 1 (Glenmark (G&G)) | $ 6.93 |
Trigova-HP 10000 IU AMP / 1 (Glenmark (G&G)) | $ 11.61 |
Vetecor (Italy) | |
Werfachor (Austria) | |
Xoragon (Georgia) | |
Zy HCG | |
Zy HCG 2000 iu Injection (Indon (Zydus Cadila Healthcare Ltd.)) | $ 2.89 |
Zy HCG 5000 iu Injection (Indon (Zydus Cadila Healthcare Ltd.)) | $ 4.22 |
Zy-HCG (India) | |
Zy-HCG 2000 IU VIAL / 1 (Zydus (Indon)) | $ 2.89 |
Zy-HCG 5000 IU VIAL / 1 (Zydus (Indon)) | $ 4.22 |
2000 IU x 1's (Zydus (Indon)) | $ 2.89 |
See 517 substitutes for Pubergen |
Users | % | ||
---|---|---|---|
16-29 | 2 | 100.0% |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|